Millennium Management LLC Increases Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Millennium Management LLC increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 287.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 146,877 shares of the company’s stock after buying an additional 108,988 shares during the quarter. Millennium Management LLC owned about 0.11% of Henry Schein worth $9,415,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of HSIC. MBB Public Markets I LLC acquired a new stake in shares of Henry Schein in the second quarter worth $611,000. Deerfield Management Company L.P. Series C purchased a new position in shares of Henry Schein in the 2nd quarter valued at about $864,000. AQR Capital Management LLC boosted its position in Henry Schein by 7.6% during the second quarter. AQR Capital Management LLC now owns 83,370 shares of the company’s stock worth $5,334,000 after purchasing an additional 5,872 shares in the last quarter. Squarepoint Ops LLC grew its stake in Henry Schein by 14,686.6% in the 2nd quarter. Squarepoint Ops LLC now owns 107,055 shares of the company’s stock valued at $6,862,000 after acquiring an additional 106,331 shares during the period. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its stake in shares of Henry Schein by 59.0% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 24,613 shares of the company’s stock worth $1,578,000 after purchasing an additional 9,132 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

HSIC has been the subject of several recent research reports. Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Friday, September 20th. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a research note on Friday, June 21st. One analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Henry Schein has an average rating of “Hold” and an average price target of $77.50.

Read Our Latest Report on Henry Schein

Henry Schein Stock Up 1.0 %

Shares of NASDAQ:HSIC opened at $69.99 on Wednesday. The firm has a market capitalization of $8.96 billion, a PE ratio of 23.65, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The firm’s 50-day moving average is $70.06 and its two-hundred day moving average is $70.02.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s revenue for the quarter was up .0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 EPS. Analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.